Cell Sheet-Based Gene Therapy Market Report Infographic Image

Published : February 2026

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Cell Sheet-Based Gene Therapy Market Report 2026

Name: Cell Sheet-Based Gene Therapy Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Cell-Sheet Type (Monolayer Cell-Sheet Type, Co-Culture Cell-Sheet Type, Multilayered Cell-Sheet Type, Other Cell-Sheet Types), By Technology Type (Cell Sheet-Based Engineering Techniques, Gene Delivery Methods), By Source Type (Autologous, Allogenic, Stem-Cell Derived), By Application (Oncology, Ophthalmology, Genetic Disorders, Cardiology, Other Applications), By End-User (Hospitals And Clinics, Research And Academic Institutions, Biotech And Pharma Companies, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Cell Sheet-Based Gene Therapy Market Overview

• Cell Sheet-Based Gene Therapy market size has reached to $0.68 billion in 2025

• Expected to grow to $1.34 billion in 2030 at a compound annual growth rate (CAGR) of 14.6%

• Growth Driver: The Rising Prevalence Of Chronic And Degenerative Diseases Fueling The Growth Of The Market Due To Increasing Demand For Regenerative Treatments

• Market Trend: Advancing Autologous Gene-corrected Cell Sheet Therapies For Regenerative Medicine And Wound Healing

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Cell Sheet-Based Gene Therapy Market?

Cell sheet-based gene therapy refers to a therapeutic approach that combines gene delivery with engineered layers of living cells to achieve localized and sustained gene expression at the target site. This method preserves cell-to-cell connections and extracellular matrix components, enhancing cell survival, integration, and functional stability after transplantation. It enables precise tissue regeneration and therapeutic gene activity while minimizing systemic exposure and unintended biological effects.

The main cell-sheet types of cell sheet-based gene therapy include monolayer cell-sheet type, co-culture cell-sheet type, multilayered cell-sheet type, and other cell-sheet types. Monolayer cell-sheet type refers to a single layer of living cells engineered and cultured to deliver therapeutic genes to target tissues. These products use technologies such as cell sheet-based engineering techniques and gene delivery methods. They are derived from sources including autologous cells, allogenic cells, and stem-cell derived cells. They are applied across areas including oncology, ophthalmology, genetic disorders, cardiology, and other applications, and are used by end users including hospitals and clinics, research and academic institutions, biotechnology and pharmaceutical companies, and other end users.

Cell Sheet-Based Gene Therapy Market Report bar graph

What Is The Cell Sheet-Based Gene Therapy Market Size and Share 2026?

The cell sheet-based gene therapy market size has grown rapidly in recent years. It will grow from $0.68 billion in 2025 to $0.78 billion in 2026 at a compound annual growth rate (CAGR) of 14.4%. The growth in the historic period can be attributed to increasing advancements in tissue engineering research, early adoption of regenerative medicine techniques, growth in cell-based therapeutic studies, improvements in Gene Delivery Technologies, expansion of translational research initiatives.

What Is The Cell Sheet-Based Gene Therapy Market Growth Forecast?

The cell sheet-based gene therapy market size is expected to see rapid growth in the next few years. It will grow to $1.34 billion in 2030 at a compound annual growth rate (CAGR) of 14.6%. The growth in the forecast period can be attributed to increasing demand for localized regenerative therapies, rising clinical trials in gene-modified cell therapies, expansion of oncology and cardiology applications, growing investments in advanced tissue engineering, increasing focus on precision regenerative medicine. Major trends in the forecast period include expansion of multilayered and co-culture cell sheet technologies, rising focus on localized gene expression therapies, growing integration of regenerative medicine approaches, increased use of stem-cell derived cell sheets, enhanced focus on tissue integration and longevity.

Book your 30 minutes free consultation with our research experts

Global Cell Sheet-Based Gene Therapy Market Segmentation

1) By Cell-Sheet Type: Monolayer Cell-Sheet Type; Co-Culture Cell-Sheet Type; Multilayered Cell-Sheet Type; Other Cell-Sheet Types

2) By Technology Type: Cell Sheet-Based Engineering Techniques; Gene Delivery Methods

3) By Source Type: Autologous; Allogenic; Stem-Cell Derived

4) By Application: Oncology; Ophthalmology; Genetic Disorders; Cardiology; Other Applications

5) By End-User: Hospitals And Clinics; Research And Academic Institutions; Biotech And Pharma Companies; Other End-Users

Subsegments:

1) By Monolayer Cell-Sheet Type: Cardiomyocyte Sheets; Epithelial Cell Sheets; Mesenchymal Stem Cell Sheets; Other Monolayer Cell Sheets

2) By Co-Culture Cell-Sheet Type: Fibroblast + Stem Cell Sheets; Endothelial + Smooth Muscle Cell Sheets; Other Co-Culture Combinations

3) By Multilayered Cell-Sheet Type: Triple-Layered Sheets; Double-Layered Sheets; Other Multilayered Configurations

4) By Other Cell-Sheet Types: Genetically Modified Cell Sheets; Hybrid Cell Sheets; Other Novel Or Experimental Sheets

What Is The Driver Of The Cell Sheet-Based Gene Therapy Market?

The rising prevalence of chronic and degenerative diseases is expected to drive growth in the cell sheet-based gene therapy market. Chronic and degenerative diseases are long-term conditions, including cardiovascular disorders, neurodegenerative diseases, diabetes, and genetic disorders, that progressively damage tissues and organs and require sustained therapeutic intervention. The prevalence of these conditions is increasing due to expanding aging populations and rising life expectancy across both developed and developing economies. Cell sheet-based gene therapy supports regenerative treatment approaches for chronic and degenerative diseases by enabling localized tissue repair and sustained gene delivery through layered living cell constructs, which can improve tissue integration and long-term therapeutic outcomes. For instance, in April 2025, according to the International Diabetes Federation (IDF), a Belgium-based non-profit organization, 589 million people worldwide were living with diabetes in 2024, a figure projected to rise to 853 million by 2050. Therefore, the rising prevalence of chronic and degenerative diseases is driving the growth of the cell sheet-based gene therapy industry.

Key Players In The Global Cell Sheet-Based Gene Therapy Market

Major companies operating in the cell sheet-based gene therapy market are Hitachi Ltd., Thermo Fisher Scientific, Fujifilm Cellular Dynamics Inc. (FCDI) (FUJIFILM Holdings Corporation), Lonza Group AG, teijin regenet co. ltd., Terumo Corporation, Nikon CeLL innovation Co. Ltd., Rohto Pharmaceutical Co. Ltd., BioBridge Global, AGC Biologics, Shibuya Corporation (Shibuya Kogyo Co. Ltd.), National Resilience Inc., Takara Bio Inc., Japan Tissue Engineering Co. Ltd. (J-TEC), Medipost Co. Ltd., Cell Therapies Pty Ltd, CellSeed Inc., SCTbio, Abeona Therapeutics Inc., Foundation ENEA Tech, Cyto-Facto Inc., ENCELL Co. Ltd.

Global Cell Sheet-Based Gene Therapy Market Trends and Insights

Major companies are operating in the cell sheet-based gene therapy market are focusing on developing innovative solutions such as, autologous gene-corrected cell sheet products to enhance regenerative medicine outcomes, treatment precision, and long-term tissue repair by combining engineered cells with scaffold-free sheet constructs for targeted gene delivery and wound healing. Autologous gene-corrected cell sheet products refer to therapies where a patient’s own cells are genetically modified ex vivo, expanded into sheet constructs that preserve cell-to-cell interactions and extracellular matrix integrity, and applied directly to damaged tissues to promote functional integration and durable therapeutic effects. For instance, in April 2025, Abeona Therapeutics Inc., a US-based biopharmaceutical company, received Food and Drug Administration (FDA), a US-based federal agency approval for zevaskyn (prademagene zamikeracel), designed to treat wounds in adult and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). Zevaskyn delivers the functional COL7A1 gene via genetically corrected cell sheets, promotes clinically meaningful wound healing and pain reduction with a single application, and supports sustained type VII collagen expression at wound sites—making it a breakthrough regenerative therapy and a model for future cell sheet-based gene therapy innovations.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Cell Sheet-Based Gene Therapy Market?

In December 2023, Fondazione ENEA Tech e Biomedical, an Italy-based law foundation and investment firm, acquired Holostem Terapie Avanzate S.r.l. for an undisclosed amount. Through this acquisition, the foundation aims to preserve and enhance regenerative medicine capabilities and strengthen research and development in epithelial stem cell–based therapies within the advanced cell and gene therapy space. Holostem Terapie Avanzate S.r.l. is an Italy-based biotechnology company that specializes in developing and manufacturing cell sheet–based gene and cell therapy products, including epithelial stem cell medicinal products for treating rare and severe diseases.

Regional Insights

North America was the largest region in the cell sheet based gene therapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Cell Sheet-Based Gene Therapy Market?

The cell sheet-based gene therapy market consists of revenues earned by entities providing services such as targeted tissue regeneration, sustained gene delivery, and wound healing enhancement. The market value includes the value of related goods sold by the service provider or included within the service offering. The cell sheet-based gene therapy market also includes sales of cell culture substrates, gene delivery vectors, processing tools, and supporting technologies used in the fabrication and application of therapeutic cell sheets. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Cell Sheet-Based Gene Therapy Market Report 2026?

The cell sheet-based gene therapy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cell sheet-based gene therapy industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Cell Sheet-Based Gene Therapy Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$0.78 billion
Revenue Forecast In 2035	$1.34 billion
Growth Rate	CAGR of 14.4% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Cell-Sheet Type, Technology Type, Source Type, Application, End-User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Hitachi Ltd., Thermo Fisher Scientific, Fujifilm Cellular Dynamics Inc. (FCDI) (FUJIFILM Holdings Corporation), Lonza Group AG, teijin regenet co. ltd., Terumo Corporation, Nikon CeLL innovation Co. Ltd., Rohto Pharmaceutical Co. Ltd., BioBridge Global, AGC Biologics, Shibuya Corporation (Shibuya Kogyo Co. Ltd.), National Resilience Inc., Takara Bio Inc., Japan Tissue Engineering Co. Ltd. (J-TEC), Medipost Co. Ltd., Cell Therapies Pty Ltd, CellSeed Inc., SCTbio, Abeona Therapeutics Inc., Foundation ENEA Tech, Cyto-Facto Inc., ENCELL Co. Ltd.
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Cell Sheet-based Gene Therapy Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Cell Sheet-based Gene Therapy Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Cell Sheet-based Gene Therapy Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Cell Sheet-based Gene Therapy Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Industry 4.0 & Intelligent Manufacturing

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Artificial Intelligence & Autonomous Intelligence

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Expansion Of Multilayered And Co-Culture Cell Sheet Technologies

4.2.2 Rising Focus On Localized Gene Expression Therapies

4.2.3 Growing Integration Of Regenerative Medicine Approaches

4.2.4 Increased Use Of Stem-Cell Derived Cell Sheets

4.2.5 Enhanced Focus On Tissue Integration And Longevity

5. Cell Sheet-based Gene Therapy Market Analysis Of End Use Industries

5.1 Hospitals And Clinics

5.2 Research And Academic Institutions

5.3 Biotech Companies

5.4 Pharmaceutical Companies

5.5 Regenerative Medicine Centers

6. Cell Sheet-based Gene Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Cell Sheet-based Gene Therapy Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Cell Sheet-based Gene Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Cell Sheet-based Gene Therapy Market Size, Comparisons And Growth Rate Analysis

7.3. Global Cell Sheet-based Gene Therapy Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Cell Sheet-based Gene Therapy Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Cell Sheet-based Gene Therapy Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Cell Sheet-based Gene Therapy Market Segmentation

9.1. Global Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Monolayer Cell-Sheet Type, Co-Culture Cell-Sheet Type, Multilayered Cell-Sheet Type, Other Cell-Sheet Types

9.2. Global Cell Sheet-based Gene Therapy Market, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Cell Sheet-Based Engineering Techniques, Gene Delivery Methods

9.3. Global Cell Sheet-based Gene Therapy Market, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Autologous, Allogenic, Stem-Cell Derived

9.4. Global Cell Sheet-based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oncology, Ophthalmology, Genetic Disorders, Cardiology, Other Applications

9.5. Global Cell Sheet-based Gene Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals And Clinics, Research And Academic Institutions, Biotech And Pharma Companies, Other End-Users

9.6. Global Cell Sheet-based Gene Therapy Market, Sub-Segmentation Of Monolayer Cell-Sheet Type, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Cardiomyocyte Sheets, Epithelial Cell Sheets, Mesenchymal Stem Cell Sheets, Other Monolayer Cell Sheets

9.7. Global Cell Sheet-based Gene Therapy Market, Sub-Segmentation Of Co-Culture Cell-Sheet Type, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Fibroblast + Stem Cell Sheets, Endothelial + Smooth Muscle Cell Sheets, Other Co-Culture Combinations

9.8. Global Cell Sheet-based Gene Therapy Market, Sub-Segmentation Of Multilayered Cell-Sheet Type, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Triple-Layered Sheets, Double-Layered Sheets, Other Multilayered Configurations

9.9. Global Cell Sheet-based Gene Therapy Market, Sub-Segmentation Of Other Cell-Sheet Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Genetically Modified Cell Sheets, Hybrid Cell Sheets, Other Novel Or Experimental Sheets

10. Cell Sheet-based Gene Therapy Market Regional And Country Analysis

10.1. Global Cell Sheet-based Gene Therapy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Cell Sheet-based Gene Therapy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Cell Sheet-based Gene Therapy Market

11.1. Asia-Pacific Cell Sheet-based Gene Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Segmentation By Technology Type, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Cell Sheet-based Gene Therapy Market

12.1. China Cell Sheet-based Gene Therapy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Segmentation By Technology Type, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Cell Sheet-based Gene Therapy Market

13.1. India Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Segmentation By Technology Type, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Cell Sheet-based Gene Therapy Market

14.1. Japan Cell Sheet-based Gene Therapy Market Overview

14.2. Japan Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Segmentation By Technology Type, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Cell Sheet-based Gene Therapy Market

15.1. Australia Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Segmentation By Technology Type, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Cell Sheet-based Gene Therapy Market

16.1. Indonesia Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Segmentation By Technology Type, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Cell Sheet-based Gene Therapy Market

17.1. South Korea Cell Sheet-based Gene Therapy Market Overview

17.2. South Korea Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Segmentation By Technology Type, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Cell Sheet-based Gene Therapy Market

18.1. Taiwan Cell Sheet-based Gene Therapy Market Overview

18.2. Taiwan Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Segmentation By Technology Type, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Cell Sheet-based Gene Therapy Market

19.1. South East Asia Cell Sheet-based Gene Therapy Market Overview

19.2. South East Asia Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Segmentation By Technology Type, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Cell Sheet-based Gene Therapy Market

20.1. Western Europe Cell Sheet-based Gene Therapy Market Overview

20.2. Western Europe Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Segmentation By Technology Type, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Cell Sheet-based Gene Therapy Market

21.1. UK Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Segmentation By Technology Type, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Cell Sheet-based Gene Therapy Market

22.1. Germany Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Segmentation By Technology Type, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Cell Sheet-based Gene Therapy Market

23.1. France Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Segmentation By Technology Type, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Cell Sheet-based Gene Therapy Market

24.1. Italy Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Segmentation By Technology Type, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Cell Sheet-based Gene Therapy Market

25.1. Spain Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Segmentation By Technology Type, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Cell Sheet-based Gene Therapy Market

26.1. Eastern Europe Cell Sheet-based Gene Therapy Market Overview

26.2. Eastern Europe Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Segmentation By Technology Type, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Cell Sheet-based Gene Therapy Market

27.1. Russia Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Segmentation By Technology Type, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Cell Sheet-based Gene Therapy Market

28.1. North America Cell Sheet-based Gene Therapy Market Overview

28.2. North America Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Segmentation By Technology Type, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Cell Sheet-based Gene Therapy Market

29.1. USA Cell Sheet-based Gene Therapy Market Overview

29.2. USA Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Segmentation By Technology Type, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Cell Sheet-based Gene Therapy Market

30.1. Canada Cell Sheet-based Gene Therapy Market Overview

30.2. Canada Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Segmentation By Technology Type, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Cell Sheet-based Gene Therapy Market

31.1. South America Cell Sheet-based Gene Therapy Market Overview

31.2. South America Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Segmentation By Technology Type, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Cell Sheet-based Gene Therapy Market

32.1. Brazil Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Segmentation By Technology Type, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Cell Sheet-based Gene Therapy Market

33.1. Middle East Cell Sheet-based Gene Therapy Market Overview

33.2. Middle East Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Segmentation By Technology Type, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Cell Sheet-based Gene Therapy Market

34.1. Africa Cell Sheet-based Gene Therapy Market Overview

34.2. Africa Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Segmentation By Technology Type, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Cell Sheet-based Gene Therapy Market Regulatory and Investment Landscape

36. Cell Sheet-based Gene Therapy Market Competitive Landscape And Company Profiles

36.1. Cell Sheet-based Gene Therapy Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Cell Sheet-based Gene Therapy Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Cell Sheet-based Gene Therapy Market Company Profiles

36.3.1. Hitachi Ltd. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Thermo Fisher Scientific Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Fujifilm Cellular Dynamics Inc. (FCDI) (FUJIFILM Holdings Corporation) Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis

36.3.5. teijin regenet co. ltd. Overview, Products and Services, Strategy and Financial Analysis

37. Cell Sheet-based Gene Therapy Market Other Major And Innovative Companies

Terumo Corporation, Nikon CeLL innovation Co. Ltd., Rohto Pharmaceutical Co. Ltd., BioBridge Global, AGC Biologics, Shibuya Corporation (Shibuya Kogyo Co. Ltd.), National Resilience Inc., Takara Bio Inc., Japan Tissue Engineering Co. Ltd. (J-TEC), Medipost Co. Ltd., Cell Therapies Pty Ltd, CellSeed Inc., SCTbio, Abeona Therapeutics Inc., Foundation ENEA Tech

38. Global Cell Sheet-based Gene Therapy Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The Cell Sheet-based Gene Therapy Market

41. Cell Sheet-based Gene Therapy Market High Potential Countries, Segments and Strategies

41.1 Cell Sheet-based Gene Therapy Market In 2030 - Countries Offering Most New Opportunities

41.2 Cell Sheet-based Gene Therapy Market In 2030 - Segments Offering Most New Opportunities

41.3 Cell Sheet-based Gene Therapy Market In 2030 - Growth Strategies

41.3.1 Market Trend Based Strategies

41.3.2 Competitor Strategies

42. Appendix

42.1. Abbreviations

42.2. Currencies

42.3. Historic And Forecast Inflation Rates

42.4. Research Inquiries

42.5. The Business Research Company

42.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Cell Sheet-based Gene Therapy Market, Overview Of Key Products - Product Examples

Table 2: Global Cell Sheet-based Gene Therapy Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Cell Sheet-based Gene Therapy Market, Supply Chain Analysis

Table 4: Global Cell Sheet-based Gene Therapy Market, Major Raw Material Providers

Table 5: Global Cell Sheet-based Gene Therapy Market, Major Resource Providers

Table 6: Global Cell Sheet-based Gene Therapy Market, Major Manufacturers (Suppliers)

Table 7: Global Cell Sheet-based Gene Therapy Market, Major Distributors And Channel Partners

Table 8: Global Cell Sheet-based Gene Therapy Market, Key Technologies & Future Trends

Table 9: Global Cell Sheet-based Gene Therapy Market, Major Trends

Table 10: Global Cell Sheet-based Gene Therapy Market, Major End Users

Table 11: Global Cell Sheet-based Gene Therapy Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Cell Sheet-based Gene Therapy Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Cell Sheet-based Gene Therapy Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Cell Sheet-based Gene Therapy Market - TAM, US$ Billion, 2025

Table 15: Global Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Cell Sheet-based Gene Therapy Market, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Cell Sheet-based Gene Therapy Market, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Cell Sheet-based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Cell Sheet-based Gene Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Cell Sheet-based Gene Therapy Market, Sub-Segmentation Of Monolayer Cell-Sheet Type, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Cell Sheet-based Gene Therapy Market, Sub-Segmentation Of Co-Culture Cell-Sheet Type, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Cell Sheet-based Gene Therapy Market, Sub-Segmentation Of Multilayered Cell-Sheet Type, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Cell Sheet-based Gene Therapy Market, Sub-Segmentation Of Other Cell-Sheet Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Cell Sheet-based Gene Therapy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Global Cell Sheet-based Gene Therapy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Asia-Pacific, Cell Sheet-based Gene Therapy Market, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: Asia-Pacific, Cell Sheet-based Gene Therapy Market, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: China, Cell Sheet-based Gene Therapy Market, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: China, Cell Sheet-based Gene Therapy Market, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: India, Cell Sheet-based Gene Therapy Market, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: India, Cell Sheet-based Gene Therapy Market, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Japan, Cell Sheet-based Gene Therapy Market, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Japan, Cell Sheet-based Gene Therapy Market, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Australia, Cell Sheet-based Gene Therapy Market, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Australia, Cell Sheet-based Gene Therapy Market, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Indonesia, Cell Sheet-based Gene Therapy Market, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: Indonesia, Cell Sheet-based Gene Therapy Market, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South Korea, Cell Sheet-based Gene Therapy Market, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: South Korea, Cell Sheet-based Gene Therapy Market, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Taiwan, Cell Sheet-based Gene Therapy Market, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: Taiwan, Cell Sheet-based Gene Therapy Market, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: South East Asia, Cell Sheet-based Gene Therapy Market, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: South East Asia, Cell Sheet-based Gene Therapy Market, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Western Europe, Cell Sheet-based Gene Therapy Market, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: Western Europe, Cell Sheet-based Gene Therapy Market, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: UK, Cell Sheet-based Gene Therapy Market, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: UK, Cell Sheet-based Gene Therapy Market, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Germany, Cell Sheet-based Gene Therapy Market, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Germany, Cell Sheet-based Gene Therapy Market, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: France, Cell Sheet-based Gene Therapy Market, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: France, Cell Sheet-based Gene Therapy Market, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Italy, Cell Sheet-based Gene Therapy Market, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Italy, Cell Sheet-based Gene Therapy Market, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Spain, Cell Sheet-based Gene Therapy Market, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Spain, Cell Sheet-based Gene Therapy Market, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Eastern Europe, Cell Sheet-based Gene Therapy Market, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Eastern Europe, Cell Sheet-based Gene Therapy Market, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Russia, Cell Sheet-based Gene Therapy Market, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: Russia, Cell Sheet-based Gene Therapy Market, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: North America, Cell Sheet-based Gene Therapy Market, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: North America, Cell Sheet-based Gene Therapy Market, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: USA, Cell Sheet-based Gene Therapy Market, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: USA, Cell Sheet-based Gene Therapy Market, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Canada, Cell Sheet-based Gene Therapy Market, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: Canada, Cell Sheet-based Gene Therapy Market, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: South America, Cell Sheet-based Gene Therapy Market, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: South America, Cell Sheet-based Gene Therapy Market, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Brazil, Cell Sheet-based Gene Therapy Market, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Brazil, Cell Sheet-based Gene Therapy Market, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Middle East, Cell Sheet-based Gene Therapy Market, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Middle East, Cell Sheet-based Gene Therapy Market, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Africa, Cell Sheet-based Gene Therapy Market, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Africa, Cell Sheet-based Gene Therapy Market, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 98: Global Cell Sheet-based Gene Therapy Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 99: Global Cell Sheet-based Gene Therapy Market - Company Scoring Matrix

Table 100: Upcoming Startups

Table 101: Hitachi Ltd. Financial Performance

Table 102: Thermo Fisher Scientific Financial Performance

Table 103: Fujifilm Cellular Dynamics Inc. (FCDI) (FUJIFILM Holdings Corporation) Financial Performance

Table 104: Lonza Group AG Financial Performance

Table 105: teijin regenet co. ltd. Financial Performance

Table 106: Global Cell Sheet-based Gene Therapy Market, Competitive Benchmarking (In USD Billions)

Table 107: Global Cell Sheet-based Gene Therapy Market, Competitive Dashboard

Table 108: Global Cell Sheet-based Gene Therapy Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 109: Global, Cell Sheet-based Gene Therapy Market Size Gain ($ Billion), Segmentation By Cell-Sheet Type, 2025 – 2030

Table 110: Global, Cell Sheet-based Gene Therapy Market Size Gain ($ Billion), Segmentation By Technology Type, 2025 – 2030

Table 111: Global, Cell Sheet-based Gene Therapy Market Size Gain ($ Billion), Segmentation By Source Type, 2025 – 2030

List Of Figures

Figure 1: Global Cell Sheet-based Gene Therapy Market, Overview Of Key Products - Product Examples

Figure 2: Global Cell Sheet-based Gene Therapy Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Cell Sheet-based Gene Therapy Market, Supply Chain Analysis

Figure 4: Global Cell Sheet-based Gene Therapy Market, Major Raw Material Providers

Figure 5: Global Cell Sheet-based Gene Therapy Market, Major Resource Providers

Figure 6: Global Cell Sheet-based Gene Therapy Market, Major Manufacturers (Suppliers)

Figure 7: Global Cell Sheet-based Gene Therapy Market, Major Distributors And Channel Partners

Figure 8: Global Cell Sheet-based Gene Therapy Market, Key Technologies & Future Trends

Figure 9: Global Cell Sheet-based Gene Therapy Market, Major Trends

Figure 10: Global Cell Sheet-based Gene Therapy Market, Major End Users

Figure 11: Global Cell Sheet-based Gene Therapy Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Cell Sheet-based Gene Therapy Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Cell Sheet-based Gene Therapy Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Cell Sheet-based Gene Therapy Market - TAM, US$ Billion, 2025

Figure 15: Global Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Cell Sheet-based Gene Therapy Market, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Cell Sheet-based Gene Therapy Market, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Cell Sheet-based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Cell Sheet-based Gene Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Cell Sheet-based Gene Therapy Market, Sub-Segmentation Of Monolayer Cell-Sheet Type, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Cell Sheet-based Gene Therapy Market, Sub-Segmentation Of Co-Culture Cell-Sheet Type, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Cell Sheet-based Gene Therapy Market, Sub-Segmentation Of Multilayered Cell-Sheet Type, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Cell Sheet-based Gene Therapy Market, Sub-Segmentation Of Other Cell-Sheet Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Cell Sheet-based Gene Therapy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Global Cell Sheet-based Gene Therapy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Asia-Pacific, Cell Sheet-based Gene Therapy Market, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: Asia-Pacific, Cell Sheet-based Gene Therapy Market, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: China, Cell Sheet-based Gene Therapy Market, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: China, Cell Sheet-based Gene Therapy Market, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: India, Cell Sheet-based Gene Therapy Market, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: India, Cell Sheet-based Gene Therapy Market, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Japan, Cell Sheet-based Gene Therapy Market, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Japan, Cell Sheet-based Gene Therapy Market, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Australia, Cell Sheet-based Gene Therapy Market, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Australia, Cell Sheet-based Gene Therapy Market, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Indonesia, Cell Sheet-based Gene Therapy Market, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: Indonesia, Cell Sheet-based Gene Therapy Market, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South Korea, Cell Sheet-based Gene Therapy Market, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: South Korea, Cell Sheet-based Gene Therapy Market, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Taiwan, Cell Sheet-based Gene Therapy Market, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: Taiwan, Cell Sheet-based Gene Therapy Market, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: South East Asia, Cell Sheet-based Gene Therapy Market, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: South East Asia, Cell Sheet-based Gene Therapy Market, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Western Europe, Cell Sheet-based Gene Therapy Market, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: Western Europe, Cell Sheet-based Gene Therapy Market, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: UK, Cell Sheet-based Gene Therapy Market, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: UK, Cell Sheet-based Gene Therapy Market, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Germany, Cell Sheet-based Gene Therapy Market, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Germany, Cell Sheet-based Gene Therapy Market, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: France, Cell Sheet-based Gene Therapy Market, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: France, Cell Sheet-based Gene Therapy Market, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Italy, Cell Sheet-based Gene Therapy Market, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Italy, Cell Sheet-based Gene Therapy Market, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Spain, Cell Sheet-based Gene Therapy Market, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Spain, Cell Sheet-based Gene Therapy Market, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Eastern Europe, Cell Sheet-based Gene Therapy Market, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Eastern Europe, Cell Sheet-based Gene Therapy Market, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Russia, Cell Sheet-based Gene Therapy Market, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: Russia, Cell Sheet-based Gene Therapy Market, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: North America, Cell Sheet-based Gene Therapy Market, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: North America, Cell Sheet-based Gene Therapy Market, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: USA, Cell Sheet-based Gene Therapy Market, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: USA, Cell Sheet-based Gene Therapy Market, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Canada, Cell Sheet-based Gene Therapy Market, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: Canada, Cell Sheet-based Gene Therapy Market, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: South America, Cell Sheet-based Gene Therapy Market, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: South America, Cell Sheet-based Gene Therapy Market, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Brazil, Cell Sheet-based Gene Therapy Market, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Brazil, Cell Sheet-based Gene Therapy Market, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Middle East, Cell Sheet-based Gene Therapy Market, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Middle East, Cell Sheet-based Gene Therapy Market, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Cell Sheet-based Gene Therapy Market, Segmentation By Cell-Sheet Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Africa, Cell Sheet-based Gene Therapy Market, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Africa, Cell Sheet-based Gene Therapy Market, Segmentation By Source Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 98: Global Cell Sheet-based Gene Therapy Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 99: Global Cell Sheet-based Gene Therapy Market - Company Scoring Matrix

Figure 100: Upcoming Startups

Figure 101: Hitachi Ltd. Financial Performance

Figure 102: Thermo Fisher Scientific Financial Performance

Figure 103: Fujifilm Cellular Dynamics Inc. (FCDI) (FUJIFILM Holdings Corporation) Financial Performance

Figure 104: Lonza Group AG Financial Performance

Figure 105: teijin regenet co. ltd. Financial Performance

Figure 106: Global Cell Sheet-based Gene Therapy Market, Competitive Benchmarking (In USD Billions)

Figure 107: Global Cell Sheet-based Gene Therapy Market, Competitive Dashboard

Figure 108: Global Cell Sheet-based Gene Therapy Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 109: Global, Cell Sheet-based Gene Therapy Market Size Gain ($ Billion), Segmentation By Cell-Sheet Type, 2025 – 2030

Figure 110: Global, Cell Sheet-based Gene Therapy Market Size Gain ($ Billion), Segmentation By Technology Type, 2025 – 2030

Figure 111: Global, Cell Sheet-based Gene Therapy Market Size Gain ($ Billion), Segmentation By Source Type, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Generative AI In Creative Industries Market Report 2026 - Global Outlook – By Type (Text-To-Image Generation, Image-To-Image Generation, Music Generation, Video Generation, 3D Modeling and Animation), By Deployment Mode ...

Platelet Aggregation Devices Market Report 2026 - Global Outlook – By Product (Reagents, Systems, Consumables And Accessories), By Channel Configuration (Four Channel, Dual Channel, Eight Channel), By Technology (Optical...

Gene Therapy Market Report 2026 - Global Outlook – By Gene Therapy Type (Germline Therapy, Somatic Cell Therapy), By Vector (Viral Vector, Non-Viral Vector), By Application (Oncology, Orphan Disease, Knee Osteoarthritis,...

Nucleic Acid Based Gene Therapy Market Report 2026 - Global Outlook – By Technology (Anti-Sence and Anti-Gene, Short Inhibitory Sequences, Gene Transfer Therapy, Nucleoside Analogs, Ribozymes, Aptamers, Other Technologie...

Cell Therapy Technologies Market Report 2026 - Global Outlook – By Product (Consumables, Equipment, Systems And Software), By Cell Type (T-Cells, Stem Cells, Other Cell Types), By Process (Cell Processing, Cell Preservat...

Gout Therapeutics Market Report 2026 - Global Outlook – By Type (Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroid, Diuretics), By Treatment (Xanthine Oxidase Inhibitor, Uricosuria Medication), By Disease Con...

Frequently Asked Questions

How big is the Cell Sheet-Based Gene Therapy Market?

The Cell Sheet-Based Gene Therapy market was valued at $0.68 billion in 2025, increased to $0.78 billion in 2026, and is projected to reach $1.34 billion by 2030.

What is the Cell Sheet-Based Gene Therapy market growth?

The global Cell Sheet-Based Gene Therapy market is expected to grow at a CAGR of 14.6% from 2026 to 2035 to reach $1.34 billion by 2035.

Who are the key players in Cell Sheet-Based Gene Therapy market?

Some Key Players in the Cell Sheet-Based Gene Therapy market Include, Hitachi Ltd., Thermo Fisher Scientific, Fujifilm Cellular Dynamics Inc. (FCDI) (FUJIFILM Holdings Corporation), Lonza Group AG, teijin regenet co. ltd., Terumo Corporation, Nikon CeLL innovation Co. Ltd., Rohto Pharmaceutical Co. Ltd., BioBridge Global, AGC Biologics, Shibuya Corporation (Shibuya Kogyo Co. Ltd.), National Resilience Inc., Takara Bio Inc., Japan Tissue Engineering Co. Ltd. (J-TEC), Medipost Co. Ltd., Cell Therapies Pty Ltd, CellSeed Inc., SCTbio, Abeona Therapeutics Inc., Foundation ENEA Tech, Cyto-Facto Inc., ENCELL Co. Ltd. .

What is the anticipated growth trend for the Cell Sheet-Based Gene Therapy market?

Major trend in this market includes: Advancing Autologous Gene-corrected Cell Sheet Therapies For Regenerative Medicine And Wound Healing. For further insights on this market. request a sample here

Which region has the most growth potential in the Cell Sheet-Based Gene Therapy market?

North America was the largest region in the cell sheet based gene therapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell sheet-based gene therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.